Your browser doesn't support javascript.
loading
Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.
Li, Xin; Li, Zehao; Li, Lin; Liu, Tong; Qian, Cheng; Ren, Yanlv; Li, Zhigao; Chen, Kejin; Ji, Dongchen; Zhang, Ming; Wang, Jinsong.
Affiliation
  • Li X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Li Z; Department of Clinical Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
  • Li L; Depatment of Thyroid and Breast Surgery, Ningbo Medical Center, Li Huili Hospital, Ningbo, China.
  • Liu T; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Qian C; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Ren Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Li Z; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Chen K; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Ji D; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhang M; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Wang J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Cancer Res Treat ; 56(1): 134-142, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37591782
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Language: En Journal: Cancer Res Treat Year: 2024 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Language: En Journal: Cancer Res Treat Year: 2024 Type: Article Affiliation country: China